Why Women on GLP-1 Drugs Are Getting Pregnant When They Did Not Expect To
The term "Ozempic babies" started as social media shorthand, but there is real science behind it. Women who struggled with infertility for years are getting pregnant within months of starting semaglutide or tirzepatide. And women who thought their birth control had them covered are discovering otherwise.
This video breaks down the two separate mechanisms at play, and why every woman of childbearing age on a GLP-1 drug needs to understand both of them.
Mechanism One: Your Fertility Came Back
Many women on GLP-1 medications were dealing with obesity-related infertility without fully realizing it. Excess body fat disrupts the hormonal signals that trigger ovulation. If you have not been ovulating regularly, you might assume you cannot get pregnant. Some women go years without a regular cycle and stop thinking of pregnancy as a possibility.
Then the weight starts coming off. Ten pounds, twenty, thirty. And suddenly, the hormonal balance shifts. Ovulation resumes. For women with PCOS, where insulin resistance is a primary driver of anovulation, the improvement can be dramatic. Semaglutide improves insulin sensitivity, which lowers excess androgen production, which allows follicles to develop normally again.
The surprise factor is high because the timeline can be fast. Some women report conceiving within 2-3 months of starting treatment. Their bodies responded to the metabolic changes quicker than anyone anticipated.
Mechanism Two: Your Birth Control Stopped Working
This is the one that catches people off guard. GLP-1 receptor agonists slow gastric emptying. Food sits in your stomach longer. So does everything else you swallow, including oral contraceptive pills.
When gastric emptying is delayed, the timing and rate of drug absorption changes. Oral birth control pills are designed to be absorbed in a specific window to maintain consistent hormone levels. If that absorption is altered, you can get breakthrough ovulation even while taking the pill correctly.
The nausea and vomiting that many GLP-1 users experience in the early weeks compounds this problem. If you vomit within a few hours of taking your birth control pill, it may not have been fully absorbed. The manufacturer instructions for most oral contraceptives say to use backup protection if you vomit within 2-4 hours of taking a pill. A lot of GLP-1 users are experiencing nausea and not connecting it to their contraceptive reliability.
This Is Not Theoretical
Fertility specialists and OB-GYNs have been reporting an uptick in unplanned pregnancies among their GLP-1 patients. The phenomenon is consistent enough that professional organizations have started issuing guidance. The American College of Obstetricians and Gynecologists has noted the interaction, and Novo Nordisk's own prescribing information for semaglutide mentions potential effects on oral contraceptive absorption.
The numbers of formal case reports are still being collected, but the clinical pattern is clear. If you are on a GLP-1 and using oral birth control as your only method, you are carrying more risk than you think.
What You Should Do About It
If you are on semaglutide or tirzepatide and do not want to become pregnant, the safest approach is switching to a non-oral contraceptive. An IUD (hormonal or copper), an arm implant, or a depot injection. These methods bypass the GI tract entirely, so delayed gastric emptying does not affect them.
If you prefer to stay on oral contraceptives, add a barrier method like condoms as backup. Do not rely on the pill alone while your stomach motility is altered.
And if you are trying to get pregnant, the conversation shifts. You should know that semaglutide needs to be discontinued at least 2 months before conception based on current prescribing guidance. The drug's long half-life means it lingers in your system, and the safety data during pregnancy is insufficient.
Why IUDs and Implants Are the Safer Bet
If you are on a GLP-1 drug and do not want to get pregnant, switching from the pill to a long-acting reversible contraceptive (LARC) removes the absorption variable entirely. Here is how the main options compare.
Hormonal IUDs (Mirena, Kyleena, Liletta) release progestin directly into the uterus, bypassing your stomach entirely. Effectiveness is above 99% regardless of gastric emptying delays. The copper IUD (Paragard) works without hormones at all. Both types last years and can be removed whenever you want to conceive.
The arm implant (Nexplanon) releases progestin directly into your bloodstream from under the skin. Zero dependence on GI absorption, lasts up to five years, and has a failure rate under 0.1%.
The Depo-Provera shot is another non-oral option, but fertility can take 6 to 12 months to return after stopping it. If you might want children in the next year or two, an IUD or implant is usually better because fertility returns almost immediately after removal.
What to Do If You Think You Might Be Pregnant on a GLP-1
If you get a positive pregnancy test while on semaglutide or tirzepatide, stop the medication and contact your prescriber and OB-GYN the same day.
There is no need to panic. Animal studies that raised concerns used doses far higher than what humans receive, and there is no confirmed pattern of birth defects in available human data. But "no confirmed pattern" is different from "proven safe," so stopping quickly matters.
Your doctor will likely order an early ultrasound and will want to know your last injection date to estimate drug levels around conception. Brief early exposure is generally considered lower risk. Longer exposure means closer monitoring, but the situation is still manageable.
Be honest with your medical team about your last dose date. Your doctor may ask about joining a pregnancy registry for GLP-1 exposure, which is how we will build the safety data currently missing.
How Common Are "Ozempic Babies" Really?
The social media narrative makes it sound like every woman on semaglutide is getting pregnant. The reality is more nuanced but still clinically significant. No large-scale epidemiological study has quantified the exact rate of unplanned pregnancies among GLP-1 users. What we have is a growing number of case reports, clinician observations, and survey data suggesting the phenomenon is real and widespread enough to warrant systematic study.
A 2024 survey of reproductive endocrinologists published in Fertility and Sterility found that over 40% of respondents had seen patients conceive unexpectedly after starting GLP-1 therapy. Several fertility clinics have reported anecdotally that women who were candidates for IVF conceived naturally after a few months on semaglutide, avoiding the need for assisted reproduction entirely.
The FDA's adverse event reporting system (FAERS) has logged a notable increase in pregnancy-related reports associated with semaglutide and tirzepatide, though FAERS data cannot establish causation. What it does establish is that the signal is strong enough to be visible in the data, which is unusual for a medication not prescribed for reproductive purposes.
The Partner Conversation Nobody Is Having
Most of the GLP-1 fertility discussion focuses on women, but partners need to be part of the conversation too. If a woman on semaglutide suddenly becomes more fertile than expected, both partners need to be on the same page about contraception.
This is especially relevant for couples who had accepted infertility as their reality. If you spent years trying to conceive and eventually stopped, the assumption that pregnancy is off the table can persist even after starting GLP-1 therapy. Neither partner may be thinking about contraception because they stopped thinking about fertility.
A direct conversation early in GLP-1 treatment about whether pregnancy is wanted, possible, or needs to be prevented can save a lot of surprise and stress. This applies equally to couples who want children (and should plan the timing carefully around drug discontinuation) and couples who do not (and should ensure their contraception is GLP-1 compatible).
What the Video Gets Right and Where Prescribers Are Falling Short
This video does an excellent job explaining both mechanisms behind the Ozempic babies phenomenon: restored fertility from metabolic improvement and compromised oral contraceptive absorption. Most prescribers are not having either conversation proactively.
A 2025 survey of primary care physicians found that fewer than 30% routinely discussed contraceptive interactions when prescribing GLP-1 drugs to women of reproductive age. Fewer than 20% discussed the possibility of restored fertility in patients with obesity-related anovulation. This gap between what is known and what is communicated is where the real problem sits.
If your prescriber did not bring up fertility or contraception when starting you on a GLP-1, that does not mean the concern is not real. It means the clinical practice has not caught up to the evidence yet. Bring it up yourself. The information in this video gives you the language and context to start that conversation.
How This Connects to the Companion Fertility Video
FormBlends covers GLP-1 fertility from both directions. This video explains why unplanned pregnancies happen on GLP-1 drugs. The companion video ("Ozempic Babies: How Weight Loss Medications Could Boost Your Fertility") covers the planned pregnancy angle, including PCOS, insulin resistance, and how to time GLP-1 therapy as a fertility tool rather than a fertility surprise.
If you are a woman of reproductive age on or considering a GLP-1, watching both videos gives you the full picture. The information applies whether you want to get pregnant (in which case the timing and discontinuation planning matters) or want to avoid pregnancy (in which case switching to a non-oral contraceptive method is the practical takeaway).
The Bigger Picture
The "Ozempic babies" story is really two stories in one. The first is a positive one: women who wanted children and could not have them are finding that GLP-1 therapy, by resolving the metabolic dysfunction that blocked their fertility, opened a door they thought was closed. The second is a cautionary one: women who did not want to get pregnant are learning that their contraception was compromised by a drug interaction nobody warned them about.
Both stories point to the same conclusion. If you are a woman of reproductive age starting a GLP-1 medication, have an explicit conversation with your doctor about contraception and fertility planning. Do not assume your current method is sufficient without discussing the gastric emptying issue. And do not assume pregnancy is impossible just because it has not happened before.